Byetta Lawsuit Update: Court Considering Case Management Proposals in...
The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, thyroid cancer or pancreatitis, allegedly due to their use of the Type 2 diabetes medication.(PRWeb February 17, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11587413.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 17, 2014 Category: Pharmaceuticals Source Type: news

As Byetta Lawsuits Move Forward, Bernstein Liebhard LLP Notes New FDA...
The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic...(PRWeb February 13, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11583185.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2014 Category: Pharmaceuticals Source Type: news

Byetta Lawsuits Move Forward, as Federal and State Incretin Mimetics...
The Firm is investigating Byetta lawsuits that allege an association between the use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer.(PRWeb January 25, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11521828.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 25, 2014 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit News: More Than 260 Product Liability Claims Now...
The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, pancreatitis, or thyroid cancer, allegedly due to their use of Byetta.(PRWeb January 16, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11496700.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 17, 2014 Category: Pharmaceuticals Source Type: news

Bernstein Liebhard LLP Notes Progress in Federal Byetta Lawsuit...
The attorneys at Bernstein Liebhard LLP are actively investigating potential Byetta lawsuit claims alleging pancreatic cancer, pancreatitis and thyroid cancer caused by the diabetes medication.(PRWeb December 22, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11442741.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 23, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of...
The Firm is investigating potential Byetta lawsuits on behalf of alleged victims of Byetta and pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb December 03, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11388186.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 4, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance...
The Firm is currently investigating Byetta lawsuits that allege an association between use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer.(PRWeb November 16, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11339864.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 19, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status...
The Firm is evaluating potential Byetta lawsuits alleging an association between the use of Byetta and pancreatic cancer.(PRWeb November 08, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11316884.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 10, 2013 Category: Pharmaceuticals Source Type: news

New York Attorney Now Accepting Januvia, Janumet, Byetta or...
Commack, New York law firm, Rudolph F.X. Migliore, P.C., is accepting cases from individuals who took the prescription medication Januvia, Janumet, Byetta or Victoza and later developed pancreatic...(PRWeb November 05, 2013)Read the full story at http://www.prweb.com/releases/2013/11/prweb11297852.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 5, 2013 Category: Pharmaceuticals Source Type: news

GLP-1, TZD Combo May Cut Heart Risk (CME/CE)
(MedPage Today) -- The GLP-1 agonist exenatide (Byetta, Bydureon) may temper the cardiovascular risks associated with rosigltiazone (Avandia), possibly via its effects on a clotting pathway, a database study suggests. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 9, 2013 Category: Cardiology Source Type: news

Byetta Lawsuit News: Bernstein Liebhard LLP Notes Establishment of...
Byetta lawsuits pending in the new multidistrict litigation allege the drug’s makers failed to warn of a possible connection between Byetta and pancreatic cancer.(PRWeb August 27, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11065921.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 28, 2013 Category: Pharmaceuticals Source Type: news

Byetta May Help in Type 1 Diabetes, Too (CME/CE)
(MedPage Today) -- The GLP-1 agonist exenatide (Byetta) used in type 2 diabetes may have metabolic effects on patients with type 1 disease, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 14, 2013 Category: Cardiology Source Type: news

Byetta Lawsuit Investigation Being Conducted by Bernstein Liebhard LLP...
Dozens of Byetta lawsuits now pending in federal court allege the drug’s makers failed to warn of a possible connection between Byetta and pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb August 10, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11015808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 11, 2013 Category: Pharmaceuticals Source Type: news

Byetta Lawsuit - Claims Move Forward, as Panel Considers Consolidation...
The Firm is investigating alleged Byetta pancreatic cancer lawsuits, as well as claims involving Byetta and pancreatitis and thyroid cancer.(PRWeb July 26, 2013)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb10969663.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2013 Category: Pharmaceuticals Source Type: news

Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Former Eli Lilly executive brings wealth of diabetes insights, business strategy and global pharma leadership experience to Intarcia during critical time of opportunity BOSTON, July 26, 2013 -- (Healthcare Sales & Marketing Network) -- Intarcia Therape... Biopharmaceuticals, Drug Delivery, PersonnelIntarcia Therapeutics, ITCA 650, exenatide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2013 Category: Pharmaceuticals Source Type: news